Clinical and sociodemographic characteristics of cardiovascular disease in Sudan
More details
Hide details
Faculty of Medical Laboratory Science, University of Khartoum, Sudan
Sudan Heart Center, Khartoum, Sudan
Sudan Medical Specialization Boards, Khartoum, Sudan
Hassan H Musa   

Faculty of Medical Laboratory Sci., University of Khartoum, Madani Street, Khartoum, Khartoum State 00249, Sudan. Tel.: +249906547116.
Submission date: 2015-05-01
Acceptance date: 2017-10-02
Online publication date: 2018-02-02
Publication date: 2019-11-15
Pol. Ann. Med. 2018;25(1):11–16
The burden of cardiovascular disease states is stabilizing innhigh-income countries, and it continues to rise in low-to-middle-income countries.

The aim of the study was to explore the clinical and sociodemographic characteristics of cardiovascular disease risk factors in Sudan.

Material and methods:
This is a prospective cross-sectional study consisted of 123 patients with cardiovascular disease admitted to Sudan Heart Center, Khartoum, Sudan.

Results and discussion:
In total, 60.97% were females, most were 61–70-year-old, 65.85% were living in urban area and 60.66% were from northern Sudan. Physical inactivity was common for 92.68% of patients, tobacco and alcohol were used by 12.19% and 1.63% of patients, respectively. The prevalence of ischemic heart disease, cardiomyopathy, endomyocardial fibrosis, rheumatic heart disease, congenital heart disease and angina were 57.72%, 32.52%, 4.88%, 17.89%, 9.76% and 16.26%, respectively. The prevalence of risk factors for developing heart diseases stroke, diabetes mellitus, hypertension and kidney disease were 3.25%, 27.64%, 44.72% and 8.13%, respectively. Most patients have family history of heart attack 12.19%, angina 13.01%, stroke 3.25%, diabetes mellitus 37.39% and hypertension 43.90%. The anthropometric measures body weight (kg), BMI and waist-to-hip ratio were 72.32 ± 1.42, 43.87 ± 0.79 and 1.05 ± 0.06, respectively.

The results conclude that there is a high prevalence of cardiovascular disease in Sudan, and the risk factors were strongly influenced by clinical and sociodemographic characteristics of the population.

The study was supported by a grant from the Department of Scientific Research, Ministry of Higher Education, Sudan.
The authors declare that they have no conflict of interests.
Engels T, Baglione Q, Audibert M, Viallefont A, Mourji F, El Alaoui Faris M. Socioeconomic Status and Stroke Prevalence in Morocco: Results from the Rabat-Casablanca Study. PLoS ONE. 2014;9(2):e89271.
Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in lowincome and middle-income countries. Lancet. 2007;370(9603):1929–1938.
van der Sande MA, Inskip HM, Jaiteh KO, et al. Changing causes of death in the West African town of Banjul, 1942–97. Bull World Health Organ. 2001;79(2):133–141.
BeLue R, Okoror TA, Iwelunmor J, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Global Health. 2009;5:10.
Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112(26):3554–3561.
Whitty CJ, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II Study. Atherosclerosis. 1999;142(2):279–286.
Kountz DS, Levine SL. Cardiovascular risk profiling in blacks: don’t forget the lipids. Am Fam Physician. 1998;58(7):1541–1542.
Cruickshank JK, Mbanya JC, Wilks R, et al. Hypertension in four African-origin populations: current ‘Rule of Halves’, quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens. 2001;19(1):41–46.
M’Buyamba-Kabangu JR, Fagard R, Lijnen P, et al. Epidemiological study of blood pressure and hypertension in a sample of urban Bantu of Zaire. J Hypertens. 1986;4:485–491.
Mtabaji JP, Nara Y, Moriguchi Y, Yamori Y. Diet and hypertension in Tanzania. J Cardiovasc Pharmacol. 1990;16(Suppl 8):S3–5.
Glew RH, Kassam HA, Bhanji RA, Okorodudu A, VanderJagt DJ. Serum Lipid Profiles and Risk of Cardiovascular Disease in Three Different Male Populations in Northern Nigeria. J Health Popul Nutr. 2002;20(2):166–174.
Khalil SI, Elsamani EZ, Dafalla G, Kazam E. Patterns of cardiovascular disease in Sudan: hospital load and recent trends. Sudan Med J. 1984;20:25–38.
Ibrahim-Khalil S, Elhag M, Ali E, et al. An epidemiological survey of rheumatic fever and rheumatic heart disease in Sahafa Town, Sudan. J Epidemiol Community Health. 1992;46(5):477–479.
Suliman A. The state of heart disease in Sudan. Cardiovasc J Afr. 2011;22(4):191–196.
Musa HH, Tyrab EM, Muzamil M, Elbashir EA, Yahia LM, Salih NM. Charcterization of lipid profile in coronary heart disease patients in Sudan. Indian Heart J. 2013, 65(2):232–233.
Waxman A. Prevention of chronic diseases: WHO global strategy on diet, physical activity and health. Food Nutr Bull. 2003;24(3):281–284.
The ACCESS Investigators. Management of acute coronary syndromes in developing countries: acute coronary events-a multinational Survey of current management strategies. Am Heart J. 2011;162(5):852–859.e22.
Baingana FK, Bos ER. Changing patterns of disease and mortality in Sub-Saharan Africa: an overview. In: Jamison DT, Feachem RG, MAKGOBA MW., et al., eds. Disease and Mortality in Sub-Saharan Africa. 2nd Ed. Washington DC: World Bank; 2006.
Yach D, Hawkes C, Gould CL, Hofman K. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291(21):2616–2622.
Popkin BM. Dynamics of the nutrition transition and its implications for the developing world. Forum Nutr. 2003;56:262–264.
Asfaw A. The effects of obesity on doctor-diagnosed chronic diseases in Africa: empirical results from Senegal and South Africa. J Public Health Policy. 2006;27(3):250–264.
Dallongevillle J, De Bacquer D, Heidrich J, et al. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart. 2010;96(21):1744–1749.
Piano MR, Benowitz NL, FitzGerald GA, et al. Impact of smokeless tobacco products on cardiovascular disease: Implications for policy, prevention, and treatment: A Policy Statement From the American Heart Association. Circulation. 2010;122(15):1520–1544.
Pinto BM, Rabin C, Farrell N. Lifestyle and coronary heart disease prevention. Prim Care. 2005;32(4):947–961.
Ali SK. Endomyocardial fibrosis: an under-diagnosed cause of cardiomyopathy in Sudanese children. J Trop Pediat. 2009;55(5):343–346.
Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010;375(9733):2254–2266.
Ogbera AO, Fasanmade OA, Chinenye S, Akinlade A. Characterization of lipid parameters in diabetes mellitus a Nigerian report. Int Arch Med. 2009;2(1):19.
Amooah AGB. Spectrum of cardiovascular disorders in a national referral centre, Ghana. East Afr Med J. 2000;77(12):648–653.
Kingue S, Binam F, Pouth SF, Ouankou MD, Muna WF. Coronary artery disease in Cameroon: epidemiological and clinical aspects (30 cases). Ann Oncol. 2000;26:7–11.
Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED. Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord. 2001;25(11):1689–1697.
Borné Y, Hedblad B, Essén B, Engström G. Anthropometric measures in relation to risk of heart failure hospitalization: a Swedish population-based cohort study. Eur J Public Health. 2014;24(2):215–220.
Choi S, Tan E. Anthropometric measures and lipid CHD risk factors in Korean Immigrants with type 2 diabetes. J Cardiovasc Nurs. 2011;26(5):414–422.